Biotherapeutics company providing recombinant, plasma-derived and cell and gene products.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | SPLITOAK STRATEGIES LLC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— |
| Firm | Filings | Expenses |
|---|---|---|
| SPLITOAK STRATEGIES LLC | 9 | — |
| Issue | Activities |
|---|---|
| Health Issues | 9 |
| Medicare/Medicaid | 7 |